Rozlyn Khan, a Stage 4 breast cancer survivor, recently spoke out about Hina Khan's public statements surrounding her cancer journey, accusing the actress of exaggerating and using her treatment for publicity.
New Delhi [India] / London [UK] / Munich [Germany], January 28: Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity testing, powered by AI-driven technology. This innovation provides oncologists with real-time visual evidence of chem
New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with better long-term survival than wedge resection for patients with early-stage non-small cell lung cancer (NSCLC)
New Delhi [India], January 25: A three-day conference on Peritoneal Surface malignancy was held at Thangam Hospital and Cancer Center, Namakkal. Peritoneal Surface malignancy (PSM) is a super special branch dealing with cancers of peritoeum and which are spread to peritoneum. It is believe
The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor T-cell (CAR-T) therapy under the leadership of Prof. Sandeep Bansal (Medical Superintendent), a novel treatment for certain types of lymphoma and blood cancers.
London [UK]/ Munich [Germany]/ New Delhi [India], January 22: Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease (MRD) monitoring blood test for solid organ cancers. Target-MRD is a blood test based on tumor-agnostic next-generation s
External Affairs Minister (EAM) S Jaishankar spoke about India's relationship with its neighbourhood countries and noted that ties with Pakistan remain an exception due to Pakistan's support for cross-border terrorism. He also highlighted India's help towards Sri Lanka and how the country's
Karnataka Minister Madhu Bangarappa on Saturday said that Centre should announce that arecanut is not injurious to health, responding to the WHO's classification of it as a cancer-causing.
Bioengineers have developed a new construction kit for building custom sense-and-respond circuits in human cells. The research could revolutionize therapies for complex conditions like autoimmune disease and cancer.